Filter Results:
(351)
Show Results For
- All HBS Web
(351)
- People (2)
- News (140)
- Research (128)
- Events (2)
- Multimedia (6)
- Faculty Publications (71)
Show Results For
- All HBS Web
(351)
- People (2)
- News (140)
- Research (128)
- Events (2)
- Multimedia (6)
- Faculty Publications (71)
- 26 Jan 2021
- News
Clubs See Wealth in FemTech; Health Care Alumni Look at COVID Response
sharing how they were tapped to confront the COVID crisis. “On the sixth of May, I got a call from the Prime Minister asking me to take on this role,” said Bingham, who leads biotech investments as Managing Partner at SV Health Investors.... View Details
Keywords: Margie Kelley
- 01 Jun 2018
- News
Up by the Roots
establishing a platform for building relationships among the relevant actors—to be a replicable model of ecosystem development that could be applied anywhere, and to any industry. (At the moment, she is attempting to strike gold twice in one place by boosting New... View Details
- 01 Mar 2018
- What Do You Think?
Two Decades Later, is the 'New Economy' Finally Here?
second of these books, Exponential Organizations (“ExOs”), explores the impact of new technologies on organizations. These are organizations driven by such things as AI, robotics, biotech and bioinformatics, data science, and 3D printing.... View Details
Keywords: by James Heskett
- 08 Jul 2021
- Blog Post
Managing Sustainable Advantage with Key ESG Co-Founders, Anne-Marie Schoonbeek and Heleen van Poecke
internship and then later back to McKinsey after graduation, where she focused on both large-cap and startups in the pharmaceuticals and biotech space. “For me, this was a way of making an impact,” said Schoonbeek. van Poecke began her... View Details
- Web
Bringing the Next Pandemic Vaccine to Your Doorstep with MIMIX - Blog: Health Supplement
next pandemic. As COVID taught us, the more we prepare now, the quicker we can get back to normal when the next pandemic hits. As I look back at Vaxess years, it has been fantastic to see life sciences grow at HBS and within the Boston View Details
- 07 Feb 2017
- First Look
First Look at New Research: February 7
case:https://cb.hbsp.harvard.edu/cbmp/product/517027-PDF-ENG Harvard Business School Case 617-022 Alnylam Pharmaceuticals: Building Value from the IP Estate (B) The leader of a pioneering biotech company in the siRNA space weighs his... View Details
Keywords: Sean Silverthorne
- 03 May 2011
- First Look
First Look: May 3
Business Model Gary P. Pisano, Ryan Johnson, and Carin-Isabel KnoopHarvard Business School Case 611-046 In the biotech world, the 18-year-old Munich-based company MorphoSys was a rarity: it was profitable. The company achieved this... View Details
Keywords: Sean Silverthorne
- 01 Dec 2010
- News
This Is What I Do
thus deserve our support.” The MJFF raises about $50 million a year. There are prominent backers, such as Google’s Sergey Brin and his wife, Anne Wojcicki, but nearly 55,000 other people made contributions last year. To date the MJFF has supported about ninety View Details
- 01 Sep 2012
- News
High Honors
companies, primarily in the computer and health-care realm. In the four decades since, Johnson has helped build the biotech industry and earned a reputation as a thoughtful investor, trusted adviser, and generous philanthropist. Among his... View Details
- 12 May 2009
- First Look
First Look: May 12, 2009
this situation, donations are likely to decline, investment surplus has declined and biotech partners are challenged to finance joint projects as well as their own operations. Beall is striving to find a cure for cystic fibrosis while... View Details
Keywords: Martha Lagace
- 01 Sep 2009
- News
E Ink’s Wild Ride
that required a massive amount of investment before it could take off,” says Yoffie, who served on E Ink’s board from 1999 to 2004. “The truism is that getting to that point takes longer and costs more money than the most pessimistic forecast. It’s a very similar... View Details
- 25 Feb 2014
- First Look
First Look: February 25
recent firm performance? Purchase this case: http://hbr.org/product/say-on-pay-qualcomm-inc-shareholders-vote-maybe-in-2012/an/114005-PDF-ENG Harvard Business School Case 213-047 Aqua Bounty Valuation of a pre-revenue biotech company at... View Details
Keywords: Sean Silverthorne
- 28 Aug 2012
- First Look
First Look: August 28
determining a new venture's future alliance formation diminishes as the new venture's prominence in alliance networks increases. Evidence from biotech alliances between new ventures and established companies provides support for our... View Details
Keywords: Sean Silverthorne
- Web
Year in Review | Annual Report 2024
closely with leading biotech industry and biomedical authorities, receive programmatic guidance and mentorship, and join a community of entrepreneurs shaping the future of science. To date, the Blavatnik Fellows have created 35 companies... View Details
- 01 Dec 2004
- News
The Future of Stem Cells
year for research on existing lines, even as other countries are investing many times that amount. Says Cynthia Fisher (MBA ’90), president and CEO of BioMed 20/20 Technologies, a biotech and medical information products firm, “The... View Details
Keywords: Garry Emmons
- 23 Oct 2018
- First Look
New Research and Ideas, October 23, 2018
case:https://hbsp.harvard.edu/product/318082-PDF-ENG Harvard Business School Case 318-083 Sandra Brown Goes Digital (B): The Commitment Decision Sandra Brown, a middle manager at a biotech company who has led internal and external... View Details
Keywords: Dina Gerdeman
- 04 Jun 2007
- Research & Ideas
Is Health Care Making You Better—or Dead?
technological innovation, which is how the biotechs and some of the medical devices can get through these hurdles. But for a health service innovation, the payment hurdles are so massive it's masochistic. Then if you go into competition... View Details
- 01 Jun 2007
- News
Mission Possible
“Rudy contends that if we can identify the other ten or twelve genes that are players, we can give the biotech industry so many more shots to come up with a therapy,” explains McCance, who, along with his cofounders, is privately... View Details
- Web
Past Issues - Alumni
Bain & Company's Thomas J. Tierney Tackling a brave new world Complete Table of Contents June 2000 Going Public The Class of 2000 Graduates The Business of Biotech Between the lab and the boardroom, biotech... View Details
- 01 Sep 2008
- News
Mara Aspinall
ASPINALL Illustration by Jack Unruh When you ask people about their great fears in life, virtually everyone talks about cancer,” says Mara G. Aspinall (MBA ’87), past president of Genzyme Genetics, a Westborough, Massachusetts-based division of the View Details